PATENT CLAIM ANALYSIS

Application Number: 15864305
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "252110"]

Abstract:
The present invention accomplishes this by having multiple molecules of parent drugs attached to carrier moieties and by extending the period during which the parent drug is released and absorbed after administration to the patient and providing a longer duration of action per dose than the parent drug itself. Prodrug conjugates are suitable for sustained delivery of heteroaryl, lactam- amide-, imide-, sulfonamide-, carbamate-, urea-, benzamide-, acylaniline-, cyclic amide- and tertiary amine-containing parent drugs that are substituted at the amide nitrogen or oxygen atom with labile aldehyde-linked prodrug moieties. The carrier groups of the prodrugs can be hydrophobic to reduce the polarity and solubility of the parent drug under physiological conditions.

Claim (Index 84):
A method for sustained delivery of a parent drug to a patient comprising administering a prodrug compound of  claim 82 , wherein upon administration to the patient, release of the parent drug from the prodrug is sustained.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.47561
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14172391', '12823102', '13168497', '14797475', '14034918']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7842843334675783
- 35 USC 102 Novelty (BERT): 0.5308896037546295
- Combined Prediction Score: 0.7589448604962834
- Mean Citation Score: 308.1298940000001
- Max Citation Score: 314.1579
- Similarity Product: 130.47263512885272

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test